Skip to content

Research and Development of Warm Uterus Analgesia Acupoint Paste Based on Modernization Technology of Chinese Medicine

A multicenter randomized double-blind placebo-controlled clinical study of Graphene-based warm uterus analgesia acupoint paste for primary dysmenorrhea

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200058670
Enrollment
Unknown
Registered
2022-04-13
Start date
2022-05-31
Completion date
Unknown
Last updated
2024-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary dysmenorrhea

Interventions

Normal group:Graphene Warming Patch
Normal group:placebo patch

Sponsors

Changchun University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for primary dysmenorrhea 2. Regular menstrual cycle: 21 to 35 days/3 to 7 days 3. Age 18 to 35 years old 4. No previous history of severe drug allergy 5. Sign the informed consent form and voluntarily participate in the study

Exclusion criteria

Exclusion criteria: 1. Combined with organic diseases, such as endometriosis, adenomyosis, uterine fibroids, etc. 2. Combination of heart, liver, kidney and other serious primary diseases and malignant tumors, including blood ALT, AST > normal 1.5 times the upper limit of normal, blood creatinine (Cr) > the upper limit of normal 3. Patients with severe mental illness 4. Patients who are taking oral contraceptives or using the Manned Ring 5. Pregnant or lactating women, or those who have childbirth requirements during treatment 6. Those who cannot cooperate with the patching treatment 7. Those with a history of severe skin allergy, allergic to more than 2 kinds of food or drugs

Design outcomes

Primary

MeasureTime frame
Prostaglandin E2;ProstaglandinF2a;Blood routine;Urine routine;Liver and kidney function;Electrocardiogram;Gynecological ultrasound;Pregnancy;

Countries

China

Contacts

Public ContactLi Tie
litie1999@126.com13019223202

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026